U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

    [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                               ACT OF 1934

               For the quarterly period ended: September 30, 2000
                                                            ------

    [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

                           Commission File No. 0-11808

                             MB SOFTWARE CORPORATION

            Colorado                                          59-2220004
(State or other jurisdiction of                            (I.R.S. Employer
 incorporation or organization)                         Identification Number)

                      2225 E. Randol Mill Road - Suite 305
                           Arlington, Texas 76011-6306
                                 (817) 633-9400

           Securities registered pursuant to Section 12(b) of the Act:

                                                  Name of each Exchange
         Title of Each Class                      on Which Registered
         -------------------                      ---------------------
              Common                              NASDAQ - OTC BULLENTIN BOARD

Check  whether the Issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or
for shorter period that the  registrant was required to file such reports),  and
(2) has been subject to such filing requirements for the past 90 days.

                     Yes   [ X ]               No   [   ]


Check whether the  registrant  filed all  documents  and reports  required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the  distribution  of
securities under a plan confirmed by a court.

                     Yes   [ X ]               No   [   ]


As of October 31, 2000, 69,200,000 shares of the Issuer's $.001 par value common
stock were outstanding.

Transitional Small Business Disclosure Format

                     Yes   [   ]               No   [ X ]

<PAGE>

                             MB SOFTWARE CORPORATION

                                   Form 10-QSB

                        Quarter Ended September 30, 2000

                                      INDEX

PART I  -  FINANCIAL INFORMATION                                     PAGE NUMBER

       Item 1  -  Financial Statements

         Consolidated Balance Sheet
         September 30, 2000 (Unaudited) and December 31, 1999 (Audited)   F1-F2

         Consolidated Statements of Operations  -
         for the Three and  Nine Months ended September 30, 2000
         (Unaudited)                                                       F-3

         Consolidated Statements of Cash Flows
         for the Nine Months ended September 30, 2000 (Unaudited)          F-4

         Notes to Consolidated Statements                                  F-5

       Item 2  -  Management's Discussion
       and Analysis of Financial Condition and
       Results of Operations                                               3-4

PART II - OTHER  INFORMATION

       Item 5  -  Other Information                                       4-5-6


       Item 6  -  Exhibits, Financial Statement Schedules
       and Reports on Form 8-K                                              6

SIGNATURES                                                                  6



                                       2

<PAGE>

<TABLE>

<CAPTION>

                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS



                                     ASSETS
                                     ------
                                                          September 30,  December 31,
                                                               2000          1999
                                                          -------------  ------------
                                                           (Unaudited)     (Audited)
<S>                                                         <C>           <C>
   Cash                                                     $     --      $   26,078

   Medical receivables, net allowance
         for doubtful accounts and contactual
         allowances of $972,689 and $822,692 in 2000 and
        1999, respectively                                     589,359       713,625
   Notes receivable                                            275,245       177,721
   Prepaid expenses                                             19,067         4,131
                                                            ----------    ----------

           Total current assets                                883,671       921,555
                                                            ----------    ----------


PROPERTY AND EQUIPMENT, NET                                    132,515       178,525
                                                            ----------    ----------

   Note receivable - shareholder                               350,000       350,000
                                                            ----------    ----------

           Total assets                                     $1,366,186    $1,450,080
                                                            ==========    ==========

</TABLE>




                                       F1

<PAGE>

<TABLE>

<CAPTION>

                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS



                      LIABILITIES AND SHAREHOLDERS' DEFICIT
                      -------------------------------------
                                                                          September 30,   December 31,
                                                                               2000           1999
                                                                           -----------    -----------
                                                                           (Unaudited)     (Audited)
<S>                                                                        <C>            <C>
CURRENT LIABILITIES
       Cash Overdraft                                                      $    35,356    $      --
       Current maturities of notes payable                                   1,519,714      1,057,925
       Current maturities of capital leases                                      1,434         17,434
       Accounts payable                                                        303,547        402,410
       Accrued liabilities                                                     359,387        346,639
      Other liabilities                                                         20,811           --
                                                                           -----------    -----------

                    Total current liabilities                                2,240,249      1,824,408

LONG TERM DEBT
       Capital leases                                                            1,662          3,050
                                                                           -----------    -----------

             Total long term liabilities                                         1,662          3,050
                                                                           -----------    -----------

            TOTAL LIABILITIES                                                2,241,911      1,827,458

SHAREHOLDERS' DEFICIT
     Series A senior cumulative convertible particpating preferred
         stock; $10 par value; 340,000 shares issued and outstanding
          in 2000 and 1999; dividends in arrears 2000 $640,644, and          3,400,000      3,400,000
         1999, $385,644
     Undesignated preferred stock; $10 par value; 660,000 shares
       authorized; none issued                                                    --             --
       Common stock .001 par value;150,000,000 shares
          authorized; 69,200,000 shares issued in 2000 and 1999                 69,200         69,200
       Additional paid-in capital                                            1,182,382      1,103,005
       Accumulated deficit                                                  (5,515,268)    (4,937,544)
       Treasury stock, at cost; 408,029 shares                                 (12,039)       (12,039)
                                                                           -----------    -----------

                    Total shareholders' deficit                               (875,725)      (377,378)
                                                                           -----------    -----------

                                                                           $ 1,366,186    $ 1,450,080
                                                                           ===========    ===========

</TABLE>

                                       F2

<PAGE>

<TABLE>

<CAPTION>

                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF OPERATIONS

                                    UNAUDITED

                                                                  Three Months Ended                      Nine Months Ended
                                                       --------------------------------------  -------------------------------------
                                                       September 30, 2000  September 30, 1999  September 30, 2000  September 30,1999
                                                       ------------------  ------------------  ------------------  -----------------
<S>                                                        <C>                 <C>                 <C>                 <C>
REVENUES
  Medical income - net of contractual
   Adjustments of $356,090 and $17,474 and $1,083,712
   and $745,369 in 2000 and 1999, respectively             $   523,502         $   528,906         $ 1,628,573           1,626,561
  Service fees                                                   2,484                --                 2,743                --
                                                           -----------         -----------         -----------         -----------

          Total revenues                                       525,986             528,906           1,631,316           1,626,561

COST OF REVENUES
  Cost of medical services                                     398,244             304,993           1,193,118             947,376
                                                           -----------         -----------         -----------         -----------

          Total cost of revenues                               398,244             304,993           1,193,118             947,376
                                                           -----------         -----------         -----------         -----------

GROSS PROFIT                                                   127,742             223,913             438,198             679,185

OPERATING EXPENSES
  Selling, general & administrative                            302,680             426,210             902,331           1,250,687
  Depreciation and amortization                                 13,553              19,576              42,178              57,179
                                                           -----------         -----------         -----------         -----------

          Total operating expenses                             316,233             445,786             944,509           1,307,866
                                                           -----------         -----------         -----------         -----------

LOSS FROM OPERATIONS                                          (188,491)           (221,873)           (506,311)           (628,681)

OTHER INCOME (EXPENSE)
       Interest income and other                                 9,676              (5,987)             28,964                --
       Interest Expense                                        (39,227)             58,261             (99,476)               --
       Franchise Tax                                              (900)               --                  (900)
                                                           -----------         -----------         -----------         -----------
          Total other income (expense)                         (30,451)             52,274             (71,412)               --
                                                           -----------         -----------         -----------         -----------

LOSS FROM CONTINUING OPERATIONS                               (218,942)           (169,599)           (577,723)           (628,681)

DISCONTINUTED OPERATIONS
 Income (loss) from operations of discontinued subsidiary         --               108,249                --               115,600
                                                           -----------         -----------         -----------         -----------

          NET LOSS                                         $  (218,942)        $   (61,350)        $  (577,723)        $  (513,081)
                                                           ===========         ===========         ===========         ===========

Loss from continuing operations                            $  (218,942)        $  (169,599)        $  (577,723)        $  (628,681)

Plus: Cumulative preferred stock dividends                     (85,000)            (85,000)           (255,000)           (255,000)
                                                           -----------         -----------         -----------         -----------

          Loss available to common shareholders            $  (303,942)        $  (254,599)        $  (832,723)        $  (883,681)
                                                           ===========         ===========         ===========         ===========

BASIC AND DILUTED EARNINGS (L0SS) PER SHARE
  Continuing Operations                                    $     (0.00)        $     (0.01)        $     (0.01)        $     (0.01)
  Discontinued Operations                                         --                  0.00                --                  0.00

  Weighted-average common shares outstanding                69,200,000          69,100,000          69,200,000          69,100,000

</TABLE>

                                       F3

<PAGE>

<TABLE>

<CAPTION>

                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (UNAUDITED)

                                                                   NINE MONTHS          NINE MONTHS
                                                                      ENDED                ENDED
                                                               September 30, 2000   September 30, 1999
                                                               ------------------   ------------------
<S>                                                                <C>                  <C>
CASH FLOWS FROM OPERATING ACTIVITIES
       Loss from continuing operations                             $  (577,723)         $  (628,681)
       Adjustments to reconcile  loss from continuing
        operations to cash used in operating activities:
                    Depreciation                                        42,178               57,179
                    Change in allowance for doubtfull accounts            --             (1,248,968)
                    Changes in assets and liabilities:
                          Accounts receivable                         (124,266)           1,346,507
                          Prepaid expenses                              14,936               (5,257)
                          Accounts payable                             (98,862)              (9,463)
                          Accrued liabilities                          112,937              (67,245)
                                                                   -----------          -----------

Net cash used in continuing operations                                (630,800)            (555,928)

Net cash provided by (used in)  discontinued operations                 79,859             (115,600)
                                                                   -----------          -----------

Net cash used in operating activities                                 (550,941)            (671,528)
                                                                   -----------          -----------

CASH FLOWS FROM INVESTING ACTIVITIES
      Purchases of property and equipment                                 --                (13,514)
      Issuance of preferred stock dividends                               --                300,644
      Proceeds from sale of business segment                              --                550,052
      Payments on notes receivable                                     (44,894)                --
      Issuance of notes receivable                                      90,000             (228,037)
                                                                   -----------          -----------

Net cash provided by  investing activities                              45,106              609,145

CASH FLOWS FROM FINANCING ACTIVITIES
     Payments on capital leases                                        (17,388)             (70,677)
     Payments on notes payable                                          (2,010)            (183,926)
     Proceeds from new borrowings                                      364,799              180,439
     Proceeds from notes payable related parties                        99,000               10,000
     Bank overdraft                                                     35,356                 --
                                                                   -----------          -----------

Net cash provided by (used in) financing activities                    479,757              (64,164)
                                                                   -----------          -----------

NET DECREASE IN CASH                                                   (26,078)            (126,547)

 Cash at beginning of period                                            26,078              203,977
                                                                   -----------          -----------

  Cash at end of period                                            $      --            $    77,430
                                                                   ===========          ===========

SUPPLEMENTAL INFORMATION
       Cash paid during the period for interest to rela$ed party          --            $    24,225
       Cash paid during the period for interest to others               41,673               49,427
                                                                   -----------          -----------

                                                                   $    41,673          $    73,652
                                                                   ===========          ===========

</TABLE>

                                       F4

<PAGE>

NOTE 1:  BASIS OF PRESENTATION

The accompanying  unaudited consolidated financial statements have been prepared
in  accordance  with  generally  accepted  accounting   principles  for  interim
financial information and with the instructions to Form 10-QSB and Rule 10-01 of
Regulation  S-X.  They do not  include  all  information  and notes  required by
generally  accepted  accounting  principles for complete  financial  statements.
However,  except  as  disclosed,  there  has  been  no  material  change  in the
information disclosed in the notes to consolidated financial statements included
in the Annual  Report on Form  10-KSB of MB  Software  Corporation  for the year
ended  December  31,  1999.  In  the  opinion  of  management,  all  adjustments
(consisting  of  normal  recurring  accruals)  considered  necessary  for a fair
presentation  have been included.  Operating  results for the nine-month  period
ended September 30, 2000, are not necessarily indicative of the results that may
be expected for the year ending December 31, 2000.

NOTE 2:  ORGANIZATION AND NATURE OF OPERATIONS

The financial  statements  have been prepared on a going  concern  basis,  which
contemplates  realization  of  assets  and  liquidation  of  liabilities  in the
ordinary course of business.  The Company has continuously  incurred losses from
operations and has a working capital deficit.  The  appropriateness of using the
going concern basis is dependent upon the Company's ability to obtain additional
financing or equity capital and, ultimately,  to achieve profitable  operations.
These  conditions  raise  substantial  doubt  about its ability to continue as a
going  concern.  The financial  statements do not include any  adjustments  that
might result from the outcome of this uncertainty.

Management plans to raise capital by obtaining  financing through debt,  private
placement or conversion of Series A preferred  stock.  The Company believes that
these actions will enable the Company to continue  until its  operations  become
profitable.

NOTE 3:  RELATED PARTIES

Included in notes payable is related party payables of $220,000 and $889,000 for
2000 and 1999, respectively.

NOTE 4:  SALE OF CLINIC

Effective  September 1, 2000, the Company sold its South Florida  Medical Center
Clinic to a company wholly owned by two  shareholders  of the Company.  The sale
was  accomplished  by an assumption of net liabilities by the related company of
approximately  $79,000.  The net affect of the  transaction  was  recorded  as a
contribution to capital.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

General
-------

During the third  quarter  of 2000,  MB  Software  Corporation  (the  "Company")
continued  operations of its Florida health care clinics and pursued development
of online financial services for health care providers.

The health  care  division of the Company  continued  to focus on  Company-owned
physician  practices in Florida.  Florida law permits the  corporate  management
practice of medicine of the type  engaged in by the  Company.  The Company  owns
three clinics, each located in Florida.

The following  summarizes the results of operations for the  three-month and the
nine-month period ended September 30, 2000 and 1999.

Three Months Ended  September 30, 2000 Compared to Three Months Ended  September
--------------------------------------------------------------------------------
30, 1999
--------

Revenue less contractual adjustments resulting from medical activities decreased
0.01% from  $528,906  for the  three-month  period ended  September  30, 1999 to
$525,986 for the three-months ended September 30, 2000.

The cost of medical revenues  increased 30.57% to $ 398,244 for the three months
ended  September  30,  2000,  compared to $304,993  for the three  months  ended
September 30, 1999. The Company is currently reviewing operational guidelines as
part of an overall strategy to reduce costs.

                                       3

<PAGE>

The Company's  gross profit for the third quarter  decreased  75.28% to $127,742
for the third  quarter  ended  September  30,  2000 from $ 223,913 for the third
quarter ending September 1999. The Company is of the belief that the operational
costs of the healthcare clinic in South Florida were prohibitive in relations to
the profits  generated  thereby  resulting in  decreased  gross  profits.  It is
anticipated  that the  closure of the South  Florida  clinic  will  result in an
increase in gross profits

The Company's selling,  general and administrative  expenses decreased 40.81% to
$302,680 for the three months ended  September  30, 2000 as compared to $426,210
for the third quarter ending September 30, 1999. These reductions contributed to
the decreased expenses.

The net loss on  operations  decreased  17.71% to $188,491  for the  three-month
period ended  September 30, 2000 as compared to a loss of $221,873 for the three
months  ended  September  30, 1999.  The  reduction in the net loss is partially
attributable to increased operational efficiency.

Nine Months Ended September 30, 2000 Compared to Nine Months Ended September 30,
--------------------------------------------------------------------------------
1999
----

The gross medical  revenues  increased  14.35% to $2,712,285  for the nine-month
period ended  September  30, 2000,  compared to  $2,371,930  for the  nine-month
period ended September 30, 1999. This minimal increase is partially attributable
to an increase in patient volume.

The cost of medical  revenue  increased  25.93% to $1,193,118 for the nine-month
period  ended  September  30, 2000,  as compared to $947,376 for the  nine-month
period ended  September 30, 1999. The increased is due to costs attendant to the
operations of South Florida  Medical Center.  This healthcare  clinic was closed
effective August 31, 2000.

 .
Gross profit  decreased  54.96% to $679,185  for the  nine-month  period  ending
September  30, 1999 as compared to $438,198 for the nine- months  period  ending
September 30, 2000.  This  reduction in gross profits  reflects the  significant
cost associated with South Florida Medical Center. This clinic was closed August
31 2000.

The Company's selling,  general and administrative  expenses decreased 38.60% to
$902,331  for the  third  quarter  ending  September  30,  2000 as  compared  to
$1,250,687  for the third  quarter  ending  September  30, 1999.  The savings of
$348,356 represents the reductions in administrative expenses and the closing of
the South Florida Medical Center.  As such, this expense category is anticipated
to remain at a reduced level.

Net operating loss decreased 24.17% to $506,311 for the nine-month  period ended
September  30,  2000,  as compared to $628,681 for the  nine-month  period ended
September 30, 1999.  This reduction in loss reflects  other reduced  amounts for
the  nine-month  period  ending  September 30, 2000.  These amounts  include the
reduced  cost of  medical  revenue;  reduced  amount  of  selling,  general  and
administrative expenses; and the reduction in depreciation and amortization.

Liquidity and Capital Resources
-------------------------------

The  Company's  operations  used  $26,078 of cash during the  nine-months  ended
September  30, 2000  compared to a use of cash of $126,547  for the  nine-months
ended September 30, 1999.

As of  September  30,  2000,  the  Company  had a  working  capital  deficit  of
$1,356,578,  compared to the September 30, 1999 working capital of $287,827.  At
September 30, 2000, the Company had a cash overdraft of $35,356.

PART II  - OTHER INFORMATION

Item 5.  Other Information.

The  strategy  of the  Company  continues  to be to create a  national  physical
medicine network by utilizing a four-point approach consisting of:

o        Development and  implementation of a comprehensive  pain management and
         prevention program including nutritional supplements;
o        increasing  the number of clinics in which the Company has an interest,
         either through the means of acquisition,  ground-floor development,  or
         innovative partnering arrangements;
o        contracting with insurers for "total episode responsibility," and
o        the  incorporation of leading-edge  information  technology  within the
         healthcare sector.

                                       4
<PAGE>

INFORMATION TECHNOLOGY

Medical  information  technology is the cornerstone of the Company's strategy to
increase  revenue.  The  Company's  information  technology  incorporates  three
independent yet complementary facets: An Internet-based comprehensive healthcare
system  operated on the  Healthcare  Innovations,  LLC ISP;  PatientMed  2000, a
leading-edge Internet appliance that will feature physician websites and on-line
marketing of various vitamin and mineral supplements, and a Microsoft Windows(R)
based Practice Management Software System.

PatientMed 2000

Effective   July  20,  2000,   the  Company   entered  into  an  agreement  with
Screen.Phone.net  Inc.  whereby the Company  acquired  an  exclusive  license in
connection  with  PatientMed  2000_.  PatientMed  2000_  is a  ScreenPhone  - an
appliance  incorporating  a telephone,  alphanumeric  keyboard,  modem and touch
screen, to provide users with telephone-based Internet access.

PatientMed  2000 provides users with an expanded array of Internet and telephone
services as well as extensive  applications  and service  packages  specifically
tailored to each segment of the healthcare market.  PatientMed 2000_ facilitates
and  features an  improved  two-way  mode of  communication  and an  information
delivery  system between the physician and patient.  By touching one icon on the
screen,  the patient is immediately  connected to the Internet.  Once connected,
the patient may "chat"  on-line with the physician or access  information  via a
secure e-mail  address  provided to each patient.  In a real-time  communication
dynamic, clinical data may be transmitted and assessments and interventions made
without the  necessity of a patient  office  visit.  Similarly,  the patient may
access the clinic e-mail  address to schedule  appointments,  obtain certain lab
results,  order clinic nutritional  products and obtain medical  information and
services directly related to the Company clinics.

Significantly,  PatientMed  2000 affords the clinic  direct  access to insurance
companies.  The clinic may use PatientMed  2000 to access and provide  insurance
information  in two-way  real-time  communications  with  participating  on-line
insurance companies.

There  is a  three-fold  market  for the  PatientMed  2000.  Prototypes  for the
PatientMed  2000 will be utilized  in all  operational  venues in the  Company's
clinics.  This will afford the Company the substantial benefit of evaluating and
further enhancing PatientMed 2000 in its intended environment. The second market
for the  PatientMed  2000  includes  medical  clinics and  ancillary  healthcare
facilities  throughout  North  America.  The third  market arena is comprised of
patient and other individual and entity users. There are a substantial number of
individuals in the U.S. that are informed consumers concerning injury prevention
and nutritional benefits.  Many are baby-boomers,  a unique group of individuals
with the resources and needs tailored to the Company's specific venues. There is
also a robust consumer market in the United States for fitness-related  services
including those attendant to injury prevention and nutritional supplements.

The growth  potential in the second and third markets appears to be substantial.
According to IDC, a division of  International  Data Group,  in their report The
Worldwide  Information  Appliance  Market  1999-2004,  the author  projects that
worldwide Internet  appliance  shipments will grow from 11 million units in 1999
to over 89 million  units in 2004.  IDC  predicts  that U.S.  unit  shipments of
lower-cost,  transportable  consumer information appliances will outnumber those
of consumer PC's by 2002. The IDC anticipates  that while the costs for Internet
appliances are expected to begin to drop  significantly  as the market  matures,
the worldwide value of Internet appliance  shipments will grow from $2.4 billion
in 1999 to more than $17 billion in 2004.

The Healthcare Innovations, LLC ISP

Clinics  acquiring the PatientMed 2000 may also acquire a  personalized,  custom
web site to be housed on the ISP to be provided by Healthcare Innovations,  LLC.
The ISP will host a unique,  new and exclusive  medical domain.  From the domain
the clinic will be able to refer  patients  to the  personalized  physician  web
site.  Each  such  web site  will  contain  a  comprehensive  marketing  unit to
facilitate  the  purchase of vitamins  and  selected  herbs  promulgated  by the
Company.

Windows-based(R) Practice Management Software System

The Company will have a software  system  available to work in conjunction  with
PatientMed   2000.   Once  complete,   the  software  will  have  the  following
capabilities:  Complete practice management,  including billing and collections;
flexible appointment scheduling; extensive claims tracking capability; selective
patient  demographic  reporting;  simple to use interface;  seamless  integrated
electronic  claims/statements;  fully  customized  superbills;  state of the art
Internet connectivity; and unlimited fee schedule maintenance.

                                       5
<PAGE>

PAIN MANAGEMENT

The Company's four-point approach incorporates development and implementation of
a comprehensive  pain management and prevention  program.  The Company's premise
for this goal is providing superior pain management care to its patients through
utilization  of  standardized  "best  practice  outcomes"  or clinical  pathways
established  throughout  the Company and consistent  with accepted  standards of
medical practice. This will include a complementary nutritional products line.

CLINIC GROWTH

The nexus of the four  points  focuses  on  increasing  the number of clinics in
which the Company has a qualitative as well as financial interest. To expand the
Company's  clinic base,  the Company  intends to utilize  innovative  partnering
arrangements.  The Company will only partner with  professionals  that share the
Company's vision of providing superior service and experience to patients.  This
will include medical doctors, osteopaths and chiropractors. The Company may also
consider  acquisition of existing clinics and the controlled  development of new
practices in selected cities.

TOTAL EPISODIC CARE

The Company has  developed  strategic  partnerships  with  insurers in which the
Company-managed  clinicians will have clinical and financial  responsibility for
total  episodic  care.  The Company  currently  has  structured an alliance with
United  Healthcare and Humana,  major  healthcare  forces in markets wherein the
Company clinics  transact  business.  As a product of the alliance,  the Company
acquired  one of the few  Pre-Approved  Pain  Management  care  contracts in the
United  States.  For episodes  such as low-risk,  spinal  -related  injury,  the
Company  clinicians will receive global payments  covering not only professional
services,  but also facility and ancillary  care. This  arrangement  will enable
clinicians to share in the  healthcare  and economic  value created by improving
care across the entire spectrum of services.

With this four-point  strategy,  the Company will continue to build a nationwide
organization  to provide  superior  healthcare  services for patients as well as
economic value for its shareholders.

ITEM 6.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES
              AND REPORTS ON FORM 8-K

Exhibits  -  10.1
--------

             10.2  Financial  Statements - See Item 1 for  financial  statements
                                           filed with this report.

Reports on Form 8-K  - None
-------------------

--------------------------------------------------------------------------------
                                   SIGNATURES

In accordance  with the  requirements  of the Exchange Act, the  registrant  has
caused this report to be signed on its behalf by the undersigned  thereunto duly
authorized.

                                         MB SOFTWARE CORPORATION

Date: 16th November, 2000                 /s/ Scott A. Haire
                                         ----------------------
                                         Scott A.  Haire, Chairman of the Board,
                                         Chief Executive Officer and President
                                         (Principal Financial Officer)




                                       6